NPPA fixes retail prices for 41 drug combinations, including empagliflozin
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…
Drug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist Degrees
Patna: A drug inspector in Bihar has been dismissed from service following the discovery of Rs 4 crore in cash during a raid in 2022, along with evidence of extensive corruption,…
Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals
New Delhi : The Crime Branch of Delhi Police has busted a racket selling spurious cancer medicines and injections, arresting six individuals and seizing several high-value spurious cancer drugs on…
‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York
New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in…
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million
Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…
Ananda Pharma advances CBD drug with Phase 1 study listing
LONDON – Ananda Pharma PLC (AQSE:ANA), a UK-based biopharmaceutical company, has announced the publication of its Phase 1 pharmacokinetic study on the clinical trial registry clinicaltrials.gov, with the reference number…
With Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’
AiMed showers unqualified praise on Government for jettisoning foreign favoritism New Delhi: Rajiv Nath, one of the greatest champions of Make in India and no nonsense leader of domestic medical…
Medical representatives barred from govt hospitals to stop pharma influence
Medical representatives will no longer be permitted to meet doctors directly within central government hospitals, following a directive from the Centre aimed at putting an end to the nexus between…
Generic drugs can bring hope for SMA patients’
Dr Ann Agnes Mathew, a consultant paediatric neurologist and neuromuscular specialist based in Bengaluru, treats nearly 600 SMA patients from across India. In an interview with DH’s Udbhavi Balakrishna, she…
47% of pharma MOUs from VGGS 2024 commissioned
Gandhinagar: The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that…
